Systematic analysis underlying the quality of the scientific evidence and conflicts of interest in interventional medicine subspecialty guidelines

Mayo Clinic Proceedings

Volumn 89, Issue 1, 2014, Pages 16-24

  Feuerstein, Joseph D ^a   Akbari, Mona ^a   Gifford, Anne E ^a   Hurley, Christine M ^a   Leffler, Daniel A ^a   Sheth, Sunil G ^a   Cheifetz, Adam S ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMERICAN ASSOCIATION FOR BRONCHOLOGY AND INTERVENTIONAL PULMONOLOGY; AMERICAN SOCIETY FOR GASTROINTESTINAL ENDOSCOPY; ARTICLE; CONFLICT OF INTEREST; EVIDENCE BASED MEDICINE; HUMAN; MEDICAL SOCIETY; PRACTICE GUIDELINE; PUBLISHING; SCIENTIFIC LITERATURE; SOCIETY FOR CARDIOVASCULAR ANGIOGRAPHY AND INTERVENTIONS; SYSTEMATIC REVIEW; TOTAL QUALITY MANAGEMENT;

EID: 84893123815     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mayocp.2013.09.013     Document Type: Article

References (28)

1. Institute of Medicine. Guidelines for Clinical Practice: From Development to Use. Washington, DC: National Academies Press; 1992.
2. Committee on Standards for Developing Trustworthy Clinical Practice Guidelines, Institute of Medicine. Clinical Practice Guidelines We Can Trust. Washington, DC: National Academies Press; 2011.
3. Brouwers MC, Kho ME, Browman GP, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ. 2010;182(18):E839- E842.
4. AGREE: advancing the science of practice guidelines website. http://www.agreetrust.org. Accessed September 30, 2012.
5. Lo B, Field MJ; Committee on Conflict of Interest in Medical Research Education and Practice, Institute of Medicine. Conflict of Interest in Medical Research, Education, and Practice. Washington, DC: National Academies Press; 2009.
6. Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J. Potential benefits, limitations, and harms of clinical guidelines. BMJ. 1999;318(7182):527-530.
7. Neuman J, Korenstein D, Ross JS, Keyhani S. Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional study. BMJ. 2011;343:d5621.
8. Choudhry NK, Stelfox HT, Detsky AS. Relationships between authors of clinical practice guidelines and the pharmaceutical industry. JAMA. 2002;287(5):612-617.
9. Tricoci P, Allen JM, Kramer JM, Califf RM, Smith SC Jr. Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA. 2009;301(8):831-841.
10. Lee DH, Vielemeyer O. Analysis of overall level of evidence behind Infectious Diseases Society of America practice guidelines. Arch Intern Med. 2011;171(1):18-22.
11. Rowe IA, Parker R, Armstrong MJ, King AL, Houlihan DD, Mutimer D. Assessment of the quality of evidence underlying international guidelines in liver disease. Am J Gastroenterol. 2012;107(9):1276-1282.
12. Kung J, Miller RR, Mackowiak PA. Failure of clinical practice guidelines to meet Institute of Medicine standards: two more decades of little, if any, progress. Arch Intern Med. 2012;172(21):1628-1633.
13. Mendelson TB, Meltzer M, Campbell EG, Caplan AL, Kirkpatrick JN. Conflicts of interest in cardiovascular clinical practice guidelines. Arch Intern Med. 2011;171(6):577-584.
14. Guidelines for WHO guidelines. http://whqlibdoc.who.int/hq/2003/EIP-GPE- EQC-2003-1.pdf. Accessed October 15, 2012.
15. Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academies Press; 2001.
16. Bennett CL, Somerfield MR, Pfister DG, Tomori C, Yakren S, Bach PB. Perspectives on the value of American Society of Clinical Oncology clinical guidelines as reported by oncologists and health maintenance organizations. J Clin Oncol. 2003;21(5):937-941.
17. Shekelle PG, Ortiz E, Rhodes S, et al. Validity of the agency for healthcare research and quality clinical practice guidelines: how quickly do guidelines become outdated? JAMA. 2001;286(12): 1461-1467.
18. Anderson MA, Ben-Menachem T, Gan SI, et al; ASGE Standards of Practice Committee. Management of antithrombotic agents for endoscopic procedures. Gastrointest Endosc. 2009; 70(6):1060-1070.
19. CenterWatch: FDA approved drugs by therapeutic area. http://www. centerwatch.com/drug-information/fda-approvals/drugareas. aspx?AreaID1. Accessed January 1, 2013.
20. Wexner S, Beck D, Baron T, et al; American Society of Colon and Rectal Surgeons; American Society for Gastrointestinal Endoscopy; Society of American Gastrointestinal and Endoscopic Surgeons. A consensus document on bowel preparation before colonoscopy: prepared by a task force from the American Society of Colon and Rectal Surgeons (ASCRS), the American Society for Gastrointestinal Endoscopy (ASGE), and the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). Gastrointest Endosc. 2006;63(7):894-909.
21. FDA approved drug products. http://www.accessdata.fda.gov/scripts/cder/ drugsatfda/index.cfm. Accessed January 9, 2013.
22. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease). J Am Coll Cardiol. 2006;47(6):e1-e192.
23. Rooke TW, Hirsch AT, Misra S, et al. 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am College Cardiol. 2011;58(19):2020-2045.
24. GRADE Working Group. Grading the quality of evidence and the strength of recommendations. http://www.gradeworking group.org/intro.htm. Accessed September 16, 2012.
25. GRADE online learning modules. McMaster University website. http://cebgrade.mcmaster.ca. Accessed September 16, 2012.
26. Jones DJ, Barkun AN, Lu Y, et al. Conflicts of interest ethics: silencing expertise in the development of international clinical practice guidelines. Ann Intern Med. 2012;156(11):809-816.
27. Loewenstein G, Sah S, Cain DM. The unintended consequences of conflict of interest disclosure. JAMA. 2012;307(7): 669-670.
28. Council of Medical Specialty Societies. Code for interactions with companies. http://www.cmss.org/uploadedFiles/Site/CMSS-Policies/ CMSS%20Code%20for%20Interactions%20with%20 Companies%20Approved%20Revised%20Version%203-19-11 CLEAN.pdf. Published March, 2011. Accessed September 6, 2012.